These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Malignant hyperthermia: experience in the prospective management of eight children. Dubrow TJ; Wackym PA; Abdul-Rasool IH; Moore TC J Pediatr Surg; 1989 Feb; 24(2):163-6. PubMed ID: 2724006 [TBL] [Abstract][Full Text] [Related]
43. An unusual anesthetic course in a patient susceptible to malignant hyperthermia. Westlund UJ; Fridrich KL; Warner DS; Sokoll MD J Oral Maxillofac Surg; 1989 Aug; 47(8):860-4. PubMed ID: 2664105 [No Abstract] [Full Text] [Related]
44. [Anesthetic management of a patient with mental disabilities as well as the past history of heat stroke and neuroleptic malignant syndrome]. Takaishi K; Nakajo N Masui; 2007 Sep; 56(9):1078-80. PubMed ID: 17877051 [TBL] [Abstract][Full Text] [Related]
45. Malignant hyperthermia in a patient receiving nitrous oxide. Waite PD; Ballard JB; Yonfa A J Oral Maxillofac Surg; 1985 Nov; 43(11):907-9. PubMed ID: 3863903 [TBL] [Abstract][Full Text] [Related]
46. Malignant hyperthermia during epidural anesthesia. Motegi Y; Shirai M; Arai M; Kato S; Kawana Y; Goto F J Clin Anesth; 1996 Mar; 8(2):157-60. PubMed ID: 8695100 [TBL] [Abstract][Full Text] [Related]
47. Malignant hyperthermia. Robertson GR J Can Dent Assoc; 1987 Jan; 53(1):33-5. PubMed ID: 3545400 [No Abstract] [Full Text] [Related]
50. Core myopathies and malignant hyperthermia susceptibility: a review. Brislin RP; Theroux MC Paediatr Anaesth; 2013 Sep; 23(9):834-41. PubMed ID: 23617272 [TBL] [Abstract][Full Text] [Related]
51. Is lymphocyte adenosine a diagnostic marker of clinical malignant hyperthermia? A pilot study. Bina S; Capacchione J; Munkhuu B; Muldoon S; Bünger R Crit Care Med; 2015 Mar; 43(3):584-93. PubMed ID: 25479114 [TBL] [Abstract][Full Text] [Related]
52. Malignant hyperthermia. Miranda AD; Donovan LA; Schuster LL; Gerber DR Am J Crit Care; 1997 Sep; 6(5):368-74; quiz 375-6. PubMed ID: 9283674 [TBL] [Abstract][Full Text] [Related]
53. Factitious halothane detection during trigger-free anesthesia in a malignant hyperthermia susceptible patient. Hawkes CA Can J Anaesth; 1999 Jun; 46(6):567-70. PubMed ID: 10391605 [TBL] [Abstract][Full Text] [Related]
54. Propofol during cardiopulmonary bypass in a patient susceptible to malignant hyperpyrexia. Marks LF; Edwards JC; Linter SP Anaesth Intensive Care; 1988 Nov; 16(4):482-5. PubMed ID: 3266064 [No Abstract] [Full Text] [Related]
55. Epidural anesthetic management using ropivacaine in a parturient with multi-minicore disease and susceptibility to malignant hyperthermia. Saito O; Yamamoto T; Mizuno Y J Anesth; 2007; 21(1):113. PubMed ID: 17285432 [No Abstract] [Full Text] [Related]
57. Anterior mediastinal mass in a patient susceptible to malignant hyperthermia. Allen GC; Byford LJ; Shamji FM Can J Anaesth; 1993 Jan; 40(1):46-9. PubMed ID: 8425243 [TBL] [Abstract][Full Text] [Related]
58. [Malignant hyperthermia--still a current and dangerous problem]. Løvstad RZ; Halvorsen P; Steen PA; Lindal S Tidsskr Nor Laegeforen; 1995 May; 115(12):1494-8. PubMed ID: 7770853 [TBL] [Abstract][Full Text] [Related]
59. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene. Derkay CS; Grundfast KM Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251 [TBL] [Abstract][Full Text] [Related]
60. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]